BIOADAPTIVES, INC. (BDPT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 9K 18K 27K Q3 '24: 19.9K Q4 '24: 12.7K Q1 '25: 675 Q2 '25: 3.2K Q3 '25: 7.9K Q4 '25: 18.3K Q1 '26: 23.8K Q2 '26: 25.6K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 7K 14K 21K Q3 '24: 6.7K Q4 '24: 4K Q1 '25: 429 Q2 '25: 1.1K Q3 '25: 4.9K Q4 '25: 12.5K Q1 '26: 16.6K Q2 '26: 19.8K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-1.2M -800K -400K 0 400K 800K 1.2M Q3 '24: -326.5K Q4 '24: -602.1K Q1 '25: -801.4K Q2 '25: -987.6K Q3 '25: -1.1M Q4 '25: -1M Q1 '26: -991.2K Q2 '26: -909.2K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '24: -795.7K Q4 '24: -899.2K Q1 '25: -789.6K Q2 '25: -764.5K Q3 '25: -1.1M Q4 '25: -1.6M Q1 '26: -1.5M Q2 '26: -1.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 5K 10K 15K Q3 '24: 13.1K Q4 '24: 8.6K Q1 '25: 246 Q2 '25: 2.2K Q3 '25: 2.9K Q4 '25: 5.8K Q1 '26: 7.2K Q2 '26: 5.8K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-600K -400K -200K 0 200K 400K 600K Q3 '24: -240.3K Q4 '24: -249.5K Q1 '25: -306.2K Q2 '25: -365.8K Q3 '25: -460.7K Q4 '25: -516K Q1 '26: -503K Q2 '26: -436.4K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 100M 200M 300M Q1 '24: 7.7M Q2 '24: 3M Q3 '24: 8.2M Q1 '25: 9M Q2 '25: 9.5M Q3 '25: 10.2M Q1 '26: 12M Q2 '26: 281.2M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.21 -0.14 -0.07 0.00 0.07 0.14 0.21 Q3 '24: -0.10 Q4 '24: -0.09 Q1 '25: -0.07 Q2 '25: -0.15 Q3 '25: -0.19 Q4 '25: -0.15 Q1 '26: -0.14 Q2 '26: -0.12 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.